Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-001151·RAPT Therapeutics, Inc.
Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 75382E109
Event date: 2024-12-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP II, LLC
Shares: 13,193,110 · Class: 9.99%
- TCG Crossover Fund II, L.P.
Shares: 13,193,110 · Class: 9.99%
- Chen Yu
Shares: 13,193,110 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-001151
- Form type
- SCHEDULE 13G
- Filer
- RAPT Therapeutics, Inc.
- CIK
- CIK 1673772
- Filed
- Jan 03, 2025
- Reporting period
- Dec 27, 2024
- Description
- Schedule 13G beneficial ownership